Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Fallopian Tube Neoplasms, Mesothelioma, Ovarian Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT07622225 2026-06-03

SYS6006 in Combination With Enlonstobart Injection Versus Enlonstobart Injection in Participants With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

264 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT07623707 2026-06-03

A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

Phase 1/2 Not yet recruiting

264 enrolled

Other solid neoplasm

Solid Tumor

NCT06833008 2026-06-01

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

Phase 1/2 Recruiting

85 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07617493 2026-06-01

Evaluation of ICP-B208 in Patients With Advanced Solid Tumors

Phase 1/2 Not yet recruiting

539 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT01064648 2026-05-29

Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

Phase 1/2 Active not recruiting

117 enrolled 23 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT03585465 2026-05-29

Metro-PD1

Phase 1/2 Terminated

63 enrolled

Other solid neoplasm

Childhood Solid Tumor

NCT04826341 2026-05-29

A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors

Phase 1/2 Active not recruiting

35 enrolled

Other solid neoplasmThoracic

HRD Cancer

NCT05886920 2026-05-29

A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway Mutations

Phase 1/2 Active not recruiting

67 enrolled

Other solid neoplasm

Advanced Solid Tumors With MAPK Pathway Mutations

NCT07615660 2026-05-29

CVL006-T1003

Phase 1/2 Not yet recruiting

108 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05052268 2026-05-28

XTX202 in Patients With Advanced Solid Tumors

Phase 1/2 Completed

95 enrolled 49 charts

Other solid neoplasm

Advanced Solid Tumor

NCT06922357 2026-05-28

A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

120 enrolled

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT07469774 2026-05-28

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Recruiting

111 enrolled

Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

NCT07612137 2026-05-28

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Not yet recruiting

282 enrolled

Other solid neoplasm

Solid Tumor

NCT05599048 2026-05-27

Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors

Phase 1/2 Recruiting

65 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07095868 2026-05-27

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid Tumors

Phase 1/2 Recruiting

94 enrolled

Other solid neoplasm

Selected Types of Solid Tumor

NCT07228247 2026-05-27

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

Phase 1/2 Recruiting

147 enrolled

Other solid neoplasm

Solid Tumors, Adult

NCT06051695 2026-05-26

EVEREST-2

Phase 1/2 Recruiting

474 enrolled

GastrointestinalGynecologicOther solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Mesothelioma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT07446855 2026-05-26